KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Total Liabilities (2016 - 2025)

Historic Total Liabilities for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • West Pharmaceutical Services' Total Liabilities rose 1382.79% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 1382.79%. This contributed to the annual value of $1.1 billion for FY2025, which is 1382.79% up from last year.
  • West Pharmaceutical Services' Total Liabilities amounted to $1.1 billion in Q4 2025, which was up 1382.79% from $1.1 billion recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Total Liabilities ranged from a high of $1.1 billion in Q4 2025 and a low of $846.0 million during Q3 2022
  • Over the past 5 years, West Pharmaceutical Services' median Total Liabilities value was $936.2 million (recorded in 2022), while the average stood at $947.2 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Total Liabilities soared by 2041.52% in 2021, and later crashed by 1002.87% in 2022.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Total Liabilities stood at $978.4 million in 2021, then fell by 4.75% to $931.9 million in 2022, then grew by 1.78% to $948.5 million in 2023, then grew by 1.33% to $961.1 million in 2024, then grew by 13.83% to $1.1 billion in 2025.
  • Its Total Liabilities stands at $1.1 billion for Q4 2025, versus $1.1 billion for Q3 2025 and $1.0 billion for Q2 2025.